---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-029295"
form_type: "8-K"
ticker: "PTIX"
cik: "0001022899"
company_name: "Protagenic Therapeutics, Inc.new"
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T15:54:15.985399+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Protagenic Therapeutics receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period

## Summary
- Nasdaq notified PTIX on July 24, 2024 of non-compliance with minimum $1.00 bid price for 30 consecutive business days.
- Company has until January 20, 2025 to regain compliance; requires closing bid of $1.00 for at least 10 consecutive days.
- If not compliant by Jan 20, 2025, PTIX may qualify for an additional 180-day cure period if it meets other listing standards.
- Failure to cure could lead to delisting; the company may appeal any delisting determination to a Nasdaq hearings panel.

## SEC filing metadata
- accession: 0001493152-24-029295
- form_type: 8-K
- ticker: PTIX
- cik: 0001022899
- company_name: Protagenic Therapeutics, Inc.new
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022899/000149315224029295/0001493152-24-029295-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022899/000149315224029295/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-029295
- JSON: https://secwatch.observer/filing/0001493152-24-029295.json
- Plain text: https://secwatch.observer/filing/0001493152-24-029295.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.